Venture Capital Investors

EW Healthcare Partners

EW Healthcare Partners is a VC firm that backs technology-based companies.

Venture Investor Overview

Venture Investor
EW Healthcare Partners
Status
Active
Investor Type
Venture Capital
Activity Level
118 transactions
Funds Raised
Unknown
Industry Focus
Medical Devices & Instruments

Contact Information

Contact
Jeffrey Himawan
Title
Managing Director
Mailing Address
280 Park Ave. 27th Floor East
New York, NY 10017
USA
Phone
(646) 429-1251
Website
www.ewhealthcare.com
Email Address
[email protected]

Background Information

Overview
We pursue opportunities driven by a rapidly growing aging population seeking better healthcare, innovative technology and improved healthcare products. We have invested globally since 2000 with currently active investments in Europe, China, and Latin America.
Profile
EW Healthcare Partners LinkedIn Company Profile
Social Media
EW Healthcare Partners Company Twitter Account
Company News
EW Healthcare Partners News
Facebook
EW Healthcare Partners on Facebook
YouTube
EW Healthcare Partners on YouTube
Last Transaction
7/18/2023

Transaction History

Our records indicate that EW Healthcare Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
VitalConnect
7/18/2023
$30,000,000
VitalConnect
1/11/2022
$39,000,000
Cognate BioServices
1/29/2020
Unknown
Sonendo
1/8/2020
$85,000,000
TissueTech
6/27/2019
$82,250,000
COTA
2/23/2018
$40,000,000
Venus Concept
7/18/2017
$38,000,000
Xenex Disinfection Services
2/27/2017
$38,000,000
Metabolon
12/7/2016
$15,000,000
Metabolon
8/15/2016
$15,000,000
Suneva Medical
6/10/2016
$25,000,000
Encore Dermatology
3/31/2016
$12,000,000
QSpex Technologies
1/16/2014
$15,000,000
Light Sciences Oncology
12/31/2013
$350,000
IntegenX
6/30/2013
$10,000,000
Millennium Pharmacy Systems
3/31/2013
$15,000
Catalyst Biosciences
3/31/2013
$5,072,000
IntegenX
12/31/2012
$9,400,000
Serene Oncology
12/31/2012
$270,000
Precision Dermatology
12/31/2012
$25,599,900
Entellus Medical
12/31/2012
$10,000,000
BreatheAmerica
12/31/2012
$5,000,000
Kona Medical
12/4/2012
$10,000,000
IntegenX
9/30/2012
$14,440,000
White Pine Medical
6/30/2012
$6,000,000
Kona Medical
5/30/2012
$30,000,000
Bioventus
5/8/2012
$118,000,000
QSpex Technologies
12/31/2011
$6,000,000
IntegenX
12/13/2011
$40,000,000
Arsenal Medical
9/30/2011
$18,300,000
BreatheAmerica
9/7/2011
$22,000,000
Entellus Medical
8/18/2011
$35,000,000
Kona Medical
6/30/2011
$2,903,000
Velcera
6/30/2011
$5,282,000
Revance Therapeutics
6/10/2011
$45,000,000
Oraya Therapeutics
4/5/2011
$15,875,000
Open Monoclonal Technologies
3/31/2011
$4,889,000
White Pine Medical
3/31/2011
$1,000,000
Kona Medical
3/31/2011
$7,954,000
Millennium Pharmacy Systems
12/31/2010
$7,000,000
Precision Dermatology
12/31/2010
$19,000,000
Velcera
12/31/2010
$6,153,000
Oraya Therapeutics
12/31/2010
$5,000,000
Accumetrics
9/1/2010
$7,000,000
Complete Genomics
8/19/2010
$39,000,000
Revance Therapeutics
6/30/2010
$7,815,000
Velcera
6/30/2010
$29,900,000
TearScience
5/5/2010
$44,500,000
Complete Genomics
3/31/2010
$3,124,000
Horizon Pharma
3/31/2010
$7,294,000
Molecular Partners
12/15/2009
$45,000,000
Entellus Medical
11/17/2009
$30,000,000
QSpex Technologies
10/19/2009
$12,000,000
Accumetrics
10/7/2009
$16,500,000
InSound Medical
9/30/2009
$139,000
Complete Genomics
8/24/2009
$45,000,000
Xanodyne Pharmaceuticals
6/4/2009
$38,000,000
Victory Pharma
3/9/2009
$45,000,000
Millennium Pharmacy Systems
12/31/2008
$12,641,000
Touchstone Health Partnership
12/31/2008
$6,380,000
Nellix
12/31/2008
$4,000,000
Ception Therapeutics
12/31/2008
$11,033,000
ATS Medical
12/23/2008
$20,000,000
Catalyst Biosciences
12/3/2008
$40,400,000
Receptor BioLogix
9/30/2008
$1,000,000
Sound ID
6/30/2008
$750,000
Touchstone Health Partnership
6/30/2008
$660,000
Rox Medical
6/2/2008
$35,000,000
Touchstone Health Partnership
3/31/2008
$5,720,000
Open Monoclonal Technologies
3/31/2008
$9,000,000
InSound Medical
3/31/2008
$11,000,000
Nellix
3/15/2008
$6,500,000
EUSA Pharma
3/11/2008
$50,000,000
AccuRev
2/21/2008
$28,800,000
Sound ID
12/31/2007
Unknown
Revance Therapeutics
12/12/2007
$43,200,000
Corium International
9/27/2007
$25,100,000
Xanodyne Pharmaceuticals
7/27/2007
$25,000,000
Horizon Pharma
7/24/2007
$30,000,000
Merz Aesthetics
6/30/2007
$11,898,100
Prism Pharmaceuticals
6/30/2007
$7,500,000
Millennium Pharmacy Systems
6/13/2007
$40,000,000
StrataGent Life Sciences
5/10/2007
$16,000,000
Ception Therapeutics
3/31/2007
$39,683,000
Elusys Therapeutics
3/31/2007
$5,000,000
EUSA Pharma
3/1/2007
$175,000,000
Revance Therapeutics
2/22/2007
$4,000,000
Ception Therapeutics
1/31/2007
$63,000,000
Nellix
12/31/2006
$10,000,000
Medlogics Device
12/31/2006
$500,000
Serene Medical
12/31/2006
$1,000,000
NeoVista
12/8/2006
$41,000,000
EUSA Pharma
9/30/2006
$19,000,000
Prism Pharmaceuticals
9/18/2006
$68,000,000
Acura Pharmaceuticals
8/16/2006
$450,000
Elusys Therapeutics
7/13/2006
$23,000,000
Serene Medical
6/30/2006
$300,000
EUSA Pharma
6/30/2006
$1,000,000
Merz Aesthetics
6/30/2006
$11,986,000
Medlogics Device
6/30/2006
$7,900,000
Sound ID
6/30/2006
$1,000,000
Chroma Therapeutics
4/3/2006
$53,000,000
eNOS Pharmaceuticals
3/31/2006
$625,000
Acura Pharmaceuticals
1/31/2006
$750,000
AccuRev
1/20/2006
$8,250,000
Acura Pharmaceuticals
9/16/2005
$500,000
Medlogics Device
6/30/2005
$6,225,000
Acura Pharmaceuticals
6/22/2005
$1,000,000
Receptor BioLogix
4/28/2005
$33,600,000
benu
4/11/2005
$7,000,000
Revance Therapeutics
3/31/2005
$4,250,000
Confluent Surgical
3/30/2005
$23,000,000
Chroma Therapeutics
12/7/2004
$10,000,000
Catalyst Biosciences
12/4/2004
$40,000,000
MediciNova
9/3/2004
$44,000,000
AccuRev
6/21/2004
$13,500,000
Xanodyne Pharmaceuticals
6/1/2004
$20,000,000
Iomai
1/3/2003
$54,000,000

 

Investor Contacts

Title
Name
Email & Social
Managing Director
Scott Barry
  Scott Barry LinkedIn Profile  Scott Barry Twitter Account  Scott Barry News  Scott Barry on Facebook
Managing Director
Ron Eastman
  Ron Eastman LinkedIn Profile  Ron Eastman Twitter Account  Ron Eastman News  Ron Eastman on Facebook
Managing Director
Jeffrey Himawan
  Jeffrey Himawan LinkedIn Profile  Jeffrey Himawan Twitter Account  Jeffrey Himawan News  Jeffrey Himawan on Facebook
Principal
Evis Hursever
  Evis Hursever LinkedIn Profile  Evis Hursever Twitter Account  Evis Hursever News  Evis Hursever on Facebook
Managing Director
Guido Neels
  Guido Neels LinkedIn Profile  Guido Neels Twitter Account  Guido Neels News  Guido Neels on Facebook
Managing Director
Marty Sutter
  Marty Sutter LinkedIn Profile  Marty Sutter Twitter Account  Marty Sutter News  Marty Sutter on Facebook
Managing Director
Immanuel Thangaraj
  Immanuel Thangaraj LinkedIn Profile  Immanuel Thangaraj Twitter Account  Immanuel Thangaraj News  Immanuel Thangaraj on Facebook
Managing Director
Petri Vainio
  Petri Vainio LinkedIn Profile  Petri Vainio Twitter Account  Petri Vainio News  Petri Vainio on Facebook
Managing Director
Steve Wiggins
  Steve Wiggins LinkedIn Profile  Steve Wiggins Twitter Account  Steve Wiggins News  Steve Wiggins on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

EW Healthcare Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Accumetrics
AccuRev
Acura Pharmaceuticals
Arsenal Medical
ATS Medical
benu
Bioventus
BreatheAmerica
Catalyst Biosciences
Ception Therapeutics
Chroma Therapeutics
Cognate BioServices
Complete Genomics
Confluent Surgical
Corium International
COTA
Elusys Therapeutics
Encore Dermatology
eNOS Pharmaceuticals
Entellus Medical
EUSA Pharma
Horizon Pharma
InSound Medical
IntegenX
Iomai
Kona Medical
Light Sciences Oncology
MediciNova
Medlogics Device
Merz Aesthetics
Metabolon
Millennium Pharmacy Systems
Molecular Partners
Nellix
NeoVista
Open Monoclonal Technologies
Oraya Therapeutics
Precision Dermatology
Prism Pharmaceuticals
QSpex Technologies
Receptor BioLogix
Revance Therapeutics
Rox Medical
Serene Medical
Serene Oncology
Sonendo
Sound ID
StrataGent Life Sciences
Suneva Medical
TearScience
TissueTech
Touchstone Health Partnership
Velcera
Venus Concept
Victory Pharma
VitalConnect
White Pine Medical
Xanodyne Pharmaceuticals
Xenex Disinfection Services

 

 

 

 

Browse more venture capital investors:

EVX Ventures | eWTP Capital

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.